We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Cap. Flow
+$12.7B
Cap. Flow
% of AUM
18.75%
Top 10 Holdings %
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQMM
ProShares GENIUS Money Market ETF
IQMM
|
+$19.7B |
| 2 |
Walmart Inc
WMT
|
+$729M |
| 3 |
Kimberly-Clark
KMB
|
+$33.1M |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$799M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
Microsoft
MSFT
|
+$445M |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.92% |
| 2 | Consumer Staples | 7.59% |
| 3 | Consumer Discretionary | 6.94% |
| 4 | Communication Services | 6.66% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Utz Brands
UTZ
$638M
| $84.5K | ﹤0.01% |
10,674
-2,783
| -21% | -$25.9K |
|
1727
Sabre
SABR
$684M
| $84K | ﹤0.01% |
57,940
-14,227
| -20% | -$18.9K |
|
1728
Aquestive Therapeutics
AQST
$517M
| $84K | ﹤0.01% |
20,239
-4,243
| -17% | -$17.2K |
|
|
RZLV
1729
Rezolve AI
RZLV
$921M
| $82.4K | ﹤0.01% |
32,189
-493
| -2% | -$1.39K |
|
1730
Ardagh Metal Packaging
AMBP
$2.8B
| $81.9K | ﹤0.01% |
20,224
-5,274
| -21% | -$23.4K |
|
1731
Weave Communications
WEAV
$575M
| $81.8K | ﹤0.01% |
17,710
-904
| -5% | -$5.26K |
|
1732
ReNew
RNW
$2.29B
| $81.4K | ﹤0.01% |
17,773
+2,542
| +17% | +$13.5K |
|
|
TRTX
1733
TPG RE Finance Trust
TRTX
$676M
| $81K | ﹤0.01% |
10,365
-1,963
| -16% | -$16.9K |
|
1734
SunCoke Energy
SXC
$710M
| $80.2K | ﹤0.01% |
12,317
-4,198
| -25% | -$29.7K |
|
1735
Prime Medicine
PRME
$565M
| $79.9K | ﹤0.01% |
22,968
-3,190
| -12% | -$12.1K |
|
1736
Allogene Therapeutics
ALLO
$618M
| $79.6K | ﹤0.01% |
32,638
-5,396
| -14% | -$10.8K |
|
1737
Cytek Biosciences
CTKB
$597M
| $79.6K | ﹤0.01% |
18,216
-4,517
| -20% | -$21.3K |
|
1738
PagerDuty
PD
$794M
| $79.2K | ﹤0.01% |
12,753
-3,571
| -22% | -$30.9K |
|
1739
RUM Group Inc
RUM
$1.59B
| $78.9K | ﹤0.01% |
15,471
-3,963
| -20% | -$22.8K |
|
1740
FTAI Infrastructure
FIP
$492M
| $78.5K | ﹤0.01% |
15,892
-4,142
| -21% | -$23.2K |
|
1741
Sweetgreen
SG
$841M
| $77.9K | ﹤0.01% |
15,013
-3,913
| -21% | -$23.8K |
|
1742
Solid Power
SLDP
$520M
| $76.7K | ﹤0.01% |
25,551
-2,582
| -9% | -$10.4K |
|
1743
Personalis
PSNL
$1.61B
| $76.1K | ﹤0.01% |
11,950
-1,131
| -9% | -$9.55K |
|
|
NB
1744
NioCorp Developments
NB
$620M
| $76K | ﹤0.01% |
17,042
-2,522
| -13% | -$14.5K |
|
1745
Altimmune
ALT
$558M
| $75.5K | ﹤0.01% |
24,523
+3,707
| +18% | +$15.7K |
|
1746
Vanda Pharmaceuticals
VNDA
$327M
| $74.2K | ﹤0.01% |
10,731
-2,058
| -16% | -$15.9K |
|
1747
Lexeo Therapeutics
LXEO
$368M
| $73.8K | ﹤0.01% |
12,852
-1,900
| -13% | -$13.5K |
|
1748
AMC Entertainment Holdings
AMC
$1.73B
| $73.4K | ﹤0.01% |
74,930
-19,548
| -21% | -$25.2K |
|
1749
Atea Pharmaceuticals
AVIR
$390M
| $73.4K | ﹤0.01% |
13,638
-2,802
| -17% | -$12.9K |
|
1750
ASP Isotopes
ASPI
$489M
| $72.8K | ﹤0.01% |
16,481
-423
| -3% | -$2.5K |
|
Similar funds
ProShare Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 37% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.
- ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
- ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
- ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
- ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
- ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
- ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.